Low Dose Ketamine as an Adjunct to Fentanyl in Outpatient Tonsillectomy
NCT ID: NCT00587665
Last Updated: 2017-06-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
122 participants
INTERVENTIONAL
2006-08-31
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ketamine Versus Magnesium as Analgesic Adjuvants in Pediatric Adenotonsillectomy
NCT05565664
Topical Ketamine Analgesia in Children Undergoing Tonsillectomy: a Clinical and Serum Level Assays Study.
NCT02720406
Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome (OSAS) After Tonsillectomy
NCT02425202
Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy
NCT03453541
The Effect of Peritonsillar Infiltration of Ketamine and Dexamethasone for Postoperative Pain Relief in Children Following Adenotonsillectomy
NCT01198210
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Low dose ketamine given
ketamine
Single IV dose of 0.1 mg/kg of ketamine
2
Saline given as control
Placebo
Saline given of equal volume to drug
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ketamine
Single IV dose of 0.1 mg/kg of ketamine
Placebo
Saline given of equal volume to drug
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
3 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mayo Clinic, Rochester, MN
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gregory Schears, md
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic, Rochester, MN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1896-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.